Huntington’s Disease: Genetics, Pathophysiology, and Inheritance
Huntington’s disease (HD) is an autosomal dominant neurodegenerative disorder caused by a CAG trinucleotide repeat expansion in the HTT gene (chromosome 4p16.3). Normal alleles have ≤35 repeats; ≥40 repeats cause full penetrance; 36–39 repeats have reduced penetrance.
Pathogenesis
Mutant huntingtin protein (mHTT) forms aggregates, disrupts transcription, mitochondrial function, axonal transport, and synaptic signaling, leading to selective striatal and cortical neuronal loss.
Clinical Features
- Motor: chorea, dystonia, rigidity, gait impairment
- Cognitive: executive dysfunction, memory decline, dementia
- Psychiatric: depression, irritability, apathy, psychosis
Inheritance and Testing
Each child of an affected parent has a 50% chance of inheriting the expanded allele. Predictive genetic testing is available with extensive counseling. No disease‑modifying therapy exists yet; management is symptomatic and supportive.
Genetic Disorders - Related Articles
- Fragile X Premutation to Full Mutation: Expansion Mechanism
- Disease Risk Is Not Determined by Race: Socioeconomic and Lifestyle Factors Matter
- Klinefelter Syndrome (47,XXY) and Fatherhood: Fertility Options and Genetic Risks
- Sickle Cell Trait Inheritance: Does It Skip Generations?
- Splenic Sequestration in Sickle Cell Disease: Symptoms & Causes
- Hereditary Diseases: When Children Inherit Conditions Without Family History
- Parsonage-Turner Syndrome: Rare Brachial Neuritis Affecting 1-3 per 100,000
